BPA Tool for Stroke Prevention in Atrial Fibrillation
(SUPPORT-AF IV Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byAlok Kapoor, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Massachusetts, Worcester

No Placebo Group

Trial Summary

What is the purpose of this trial?Six million Americans live with atrial fibrillation (AF), a heart rhythm abnormality that is a major risk factor for stroke and only half of those AF patients receive oral anticoagulation (AC). Within the context of an ongoing collaboration between two large learning health systems, the investigators propose to study the impact of a shared clinical decision support tool embedded within the electronic health record designed to enhance guideline-based AC prescription. The hypothesis the investigators are testing is that the number of AC starts in patients seen by intervention providers will be higher than in patients seen by control providers. Additionally, the investigators are testing the hypothesis that the risk of not persisting on AC will be higher in the patients of control providers compared with patients of intervention providers.

Eligibility Criteria

This trial is for adults with atrial fibrillation or flutter who've seen a primary care provider or heart specialist in the past year and have this condition noted in their health records. It's not for those under 18, pregnant women, prisoners, patients without an AF diagnosis, those with left atrial appendage closure, or hospice patients.

Inclusion Criteria

I am 18 or older with a diagnosis of atrial fibrillation or flutter and have seen a heart specialist or primary care provider in the last year.

I am 18 or older with a diagnosis of AF or atrial flutter and have seen a heart specialist in the last year.

Exclusion Criteria

You are currently in hospice care.

You haven't been diagnosed with atrial fibrillation or atrial flutter by a primary care provider or cardiovascular medicine specialist in the past year.

I am younger than 18 years old.

+3 more

Participant Groups

The study tests if a decision support tool within electronic health records can increase prescription of oral anticoagulants (AC) to prevent strokes in AF patients. Providers are split into two groups: one uses the tool (intervention group), while the other doesn't (control group).

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Receive best practice advisory (BPA)

Group II: ControlActive Control1 Intervention

Does not receive best practice advisory (BPA)